Related Experiment Video
Updated: Jan 7, 2026

Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow
Published on: October 17, 2025
Successful treatment of atypical sprue in an infant with cyclosporine
E F Bernstein1, P F Whitington
1Department of Pediatrics, University of Chicago Pritzker School of Medicine, Wyler Children's Hospital, Illinois.
Insights
Cyclosporine effectively treated a child with severe, atypical sprue unresponsive to other therapies. The patient achieved remission, which was maintained with continued cyclosporine treatment.
Area of Science:
- Immunology
- Gastroenterology
- Pediatrics
Background:
- Atypical sprue is a severe malabsorption disorder.
- Standard treatments including diet, parenteral nutrition, and corticosteroids were ineffective.
Observation:
- A pediatric patient with refractory atypical sprue was treated with cyclosporine.
- The treatment led to rapid clinical, functional, and histologic improvement.
Findings:
- Cyclosporine induced remission of atypical sprue.
- Discontinuation of cyclosporine resulted in histologic relapse.
- Reintroduction of cyclosporine therapy led to recovery.
Implications:
- Cyclosporine shows promise as an effective treatment for severe, atypical sprue.
- Further research into cyclosporine for refractory sprue is warranted.
Abstract:
Cyclosporine was used to treat a child with severe, atypical sprue that was unresponsive to diet, parenteral nutrition, and corticosteroids. Therapy with cyclosporine resulted in a prompt clinical, functional, and histologic recovery. Remission was maintained for 1 yr until the drug was discontinued, when there was a histologic relapse that responded to reinstituting drug therapy. Cyclosporine may provide effective therapy for patients with similar disease.
More Related Videos
10:42Design to Implementation Study for Development and Patient Validation of Paper-Based Toehold Switch Diagnostics
Published on: June 17, 2022
09:39Exploring Biomolecular Interaction Between the Molecular Chaperone Hsp90 and Its Client Protein Kinase Cdc37 using Field-Effect Biosensing Technology
Published on: March 31, 2022
Related Concept Videos
08:58Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow
10:42Design to Implementation Study for Development and Patient Validation of Paper-Based Toehold Switch Diagnostics
09:39Exploring Biomolecular Interaction Between the Molecular Chaperone Hsp90 and Its Client Protein Kinase Cdc37 using Field-Effect Biosensing Technology
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
07:07Synthetic Methodology for Asymmetric Ferrocene Derived Bio-conjugate Systems via Solid Phase Resin-based Methodology
16:30BioMEMS and Cellular Biology: Perspectives and Applications